help button home button Endocrine Society Endocrinology
HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS

This Article
Right arrow Alert me when this article is cited
Right arrow Alert me if a correction is posted
Services
Right arrow Email this article to a friend
Right arrow Similar articles in this journal
Right arrow Similar articles in PubMed
Right arrow Alert me to new issues of the journal
Right arrow Download to citation manager
Right arrow Request Copyright Permission
Citing Articles
Right arrow Citing Articles via HighWire
Right arrow Citing Articles via Google Scholar
Google Scholar
Right arrow Articles by Kosugi, S.
Right arrow Articles by Imura, H.
Right arrow Search for Related Content
PubMed
Right arrow PubMed Citation
Right arrow Articles by Kosugi, S.
Right arrow Articles by Imura, H.

Endocrinology, Vol 124, 2707-2710, Copyright © 1989 by Endocrine Society


ARTICLES

Alpha 2- and beta-adrenergic receptors and adenosine A1 receptor of FRTL-5 rat thyroid cells in relation to fucosyl GM1 ganglioside

S Kosugi, T Mori, M Iwamori, Y Nagai and H Imura
Department of Internal Medicine, Kyoto University School of Medicine, Japan.

We have previously reported that anti-fucosyl GM1 ganglioside antibody partially suppresses cAMP production in FRTL-5 rat thyroid cells not via the TSH receptor but via guanine nucleotide-binding protein indirectly. In order to clarify further the mechanism of the antibody action, we studied the relationship with alpha 2- and beta-adrenergic and adenosine A1 receptors. FRTL-5 cells did not bind [3H]clonidine, suggesting the lack of alpha 2-adrenergic receptor or at least abnormality of its binding domain. On the other hand, the cells specifically bound [125I]iodocyanopindolol, but isoproterenol failed to affect the basal and TSH-stimulated cAMP production indicating the lack of coupling with adenylate cyclase. The inhibition of cAMP production induced by anti-fucosyl GM1 antibody was not altered by adrenergic agents. [125I]hydroxyphenylisopropyl adenosine binding was observed in FRTL-5 cells but was not displaced by the antibody. These results lead to conclusions that FRTL-5 cells lack alpha 2-adrenergic receptor but have beta-adrenergic receptor which lacks coupling with adenylate cyclase and have adenosine A1 receptor, and that the adrenergic receptors and adenosine A1 receptor are not the site of action of anti- fucosyl GM1 antibody.


This article has been cited by other articles:


Home page
J. Clin. Endocrinol. Metab.Home page
K. Ohta, X.-P. Pang, L. Berg, and J. M. Hershman
Growth Inhibition of New Human Thyroid Carcinoma Cell Lines by Activation of Adenylate Cyclase through the {beta}-Adrenergic Receptor
J. Clin. Endocrinol. Metab., August 1, 1997; 82(8): 2633 - 2638.
[Abstract] [Full Text] [PDF]




HOME HELP FEEDBACK SUBSCRIPTIONS ARCHIVE SEARCH TABLE OF CONTENTS
Endocrinology Endocrine Reviews J. Clin. End. & Metab.
Molecular Endocrinology Recent Prog. Horm. Res. All Endocrine Journals
Copyright © 1989 by The Endocrine Society